The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|16|3|311-325

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.16, Iss.3, 2017-04, pp. : 311-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future Prospects for the Drug Treatment of Epilepsy

By Nicolson A.   Leach J.P.  

CNS Drugs, Vol. 15, Iss. 12, 2001-01 ,pp. : 955-968

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy

By Guerrini Renzo  

Drug Safety, Vol. 35, Iss. 7, 2012-07 ,pp. : 519-533

Adis International

Access to resources Recommend Favorite

Drug safety evaluation of zonisamide for the treatment of epilepsy

By Zaccara Gaetano   Tramacere Luciana   Cincotta Massimo  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology and Drug Treatment of Epilepsy in Elderly People

By Faught E.  

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 255-269

Adis International

Access to resources Recommend Favorite

Therapeutic Impact of Sphingosine 1-phosphate Receptor Signaling in Multiple Sclerosis

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 7, 2016-05 ,pp. : 547-554

Bentham Science Publishers

Access to resources Recommend Favorite